Cancer Genetics – Products

Rapid, Highly Sensitive Detection of Structural Variants Now Possible Using Standard Short-Read Sequencing Platforms

A groundbreaking assay using short-read sequencers to comprehensively detect large structural variants.

Innovative Hi-C-like technique shows enhanced sensitivity for detecting structural variants and chromatin topology features in cancer.

Discover a single quadrupole GC-MS system that can exceed regulatory requirements and facilitate the simultaneous analysis of PAHs in water and soil samples.

Joint development collaboration to bring leading-edge nanopore sequencing into clinical laboratories at Mayo Clinic to increase understanding and improve treatment of cancer and genetic disorders.

Optibrium, announced the acquisition of BioPharmics LLC, expanding its 3D drug design and modelling offering. Bringing decades of experience in computational chemistry and biology.

Stringent safety requirements associated with the analyses of carcinogenic and mutagenic impurities can present significant challenges. Methods must achieve a high level of sensitivity and selectivity while maintaining sufficient sample throughput.

Certis Oncology Solutions has announced that three abstracts have been accepted for presentation at the upcoming American Association for Cancer Research (AACR) Annual Meeting.

PacBio has announced the availability of a new computational analysis method for profiling more than a million tandem repeats across the human genome using PacBio’s native long-read HiFi sequencing data.

A state-of-the-art former Lighthouse Lab at the Charnwood Campus was officially opened by Jane Hunt MP, having been acquired by the global whole genome sequencing company, Dante Labs.